Evidence map›Paper›PMID 40584304›Full record

ArticleACS omega2025

Putative G‑Quadruplex Structures in Dysregulated Long Non-coding RNA of Ovarian Cancer and Their Binding Interactions with Human Serum Albumin.

Deepshikha Singh, Chinmayee Shukla, Bhaskar Datta

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Phosphorylation event changes the RNA binding mode of EZH2 disordered segment.Protein science : a publication of the Protein Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Deepshikha SinghDepartment of Biological Sciences and Engineering, Indian Institute of Technology Gandhinagar, Gandhinagar 382355, Gujarat, India.
Chinmayee ShuklaDepartment of Biological Sciences and Engineering, Indian Institute of Technology Gandhinagar, Gandhinagar 382355, Gujarat, India.
Bhaskar DattaDepartment of Biological Sciences and Engineering, Indian Institute of Technology Gandhinagar, Gandhinagar 382355, Gujarat, India.ORCID https://orcid.org/0000-0002-9276-2023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long noncoding RNAs (lncRNAs) influence the progression, metastasis, and drug resistance of various cancers including ovarian cancer (OC). Putative G-quadruplex (G4)-forming sequences that are abundant in cancer-dysregulated lncRNAs have not been systematically pursued from a structure-function correlation perspective. In this work, we have used a combination of informatics, computational tools, spectroscopy, and molecular biology experiments to identify G4 formation by the OC-dysregulated lncRNAs ERLNC1, DLX6-AS1, LINC01127, FMNL1-DT, and LINP1. The in vitro ability of the lncRNAs to fold into G4 structures was accompanied by interesting profiles of individual G-tract contributions and response to monovalent cations, ligand TMPyP4, and G4-targeting antibody. Human serum albumin (HSA) was found to interact with these G4-forming lncRNAs, albeit with different affinities and structural implications for the G4 motifs. The G4-motif likely plays a crucial role in the binding interactions of select lncRNAs with HSA. This study provides the first systematic study of putative G4-forming sequences in OC-dysregulated lncRNAs and elucidates their interactions with HSA. The interaction of lncRNAs with HSA, possibly facilitated by G4 motifs, can be valuable for OC diagnosis and therapeutics.

Identifiers

PMID40584304
PMCPMC12199190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.